Dg Capital Management, LLC Gritstone Bio, Inc. Transaction History

Dg Capital Management, LLC

  • $172 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
BUY
$4.03 - $12.19 $201,500 - $609,500
50,000 New
50,000 $206,000
Q4 2021

Feb 14, 2022
SELL
$8.76 - $13.71 $728,499 - $1.14 Million
-83,162 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$6.41 - $13.54 $533,068 - $1.13 Million
83,162 New
83,162 $898,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Dg Capital Management, LLC Portfolio

Follow Dg Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dg Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email